Essential Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395 Sell
5
-62
-93% -$5.27K ﹤0.01% 2524
2026
Q1
$5.77K Buy
67
+59
+738% +$5.3K ﹤0.01% 1512
2025
Q4
$698 Buy
+8
New +$607 ﹤0.01% 2145

Other funds holding GMED

Essential Partners's GMED Position: Q2 2026 in Review

Essential Partners reduced its Globus Medical (GMED) stake by 93% in Q2 2026, selling an estimated $5.27K and leaving 5 shares worth $395. The position accounts for ﹤0.01% of the portfolio, ranked #2524.

Essential Partners first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.77K in Q1 2026. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Essential Partners held 5 shares of Globus Medical worth $395 as of Q2 2026.
  • Essential Partners sold 62 Globus Medical shares in Q2 2026, an estimated $5.27K.
  • Globus Medical made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2524 holding.
  • Essential Partners first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Essential Partners's Globus Medical position peaked at $5.77K in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.